Ayşenur ÖZTÜRK, Birsin ÖZÇAKAR, Mesiha EKİM, Nejat AKAR

Is MEFVGene Arg202Gln (605 G>A) A Disease-Causing Mutation?

Aim: Familial Mediterranean fever (FMF) is an autosomal recessive disease. Arg202Gln was reported as a frequent polymorphism, and G allele of the mutation was in linkage disequilibrium with M694V. Thus, the aim of this study was to determine the distribution of the R202Q (605G>A) mutation in exon 2 of the MEFVgene in Turkish FMF patients and controls. Materials and Methods: The study included 160 FMF and 41 FMF/amyloid patients and 121 controls. Sequencing of exon 10 and exon 5 and PCR/RFLP analysis of E148Q and R202Q mutations of exon 2 of the MEFVgene were performed for all patients according to previously described techniques. Results: We found that 5 out of 76 M694V homozygote FMF patients carry a different haplotype from the one expected. Eleven of the patients had homozygous GG allele indicating the second haplotype. None of the 121 controls was homozygous for R202Q (605G>A), but 8 controls were heterozygous for M694V mutation and 5 (4.1%) of them were in linkage disequilibrium with R202Q. Conclusions: It seems that R202Q has no effect when it is in heterozygous state; however, when combined with another disease-causing mutation, the clinical spectrum appears. Thus, R202Q might be a disease-causing mutation at least in some of the FMF patients.

Anahtar Kelimeler:

Familial Mediterranean fever (FMF), amyloidosis, MEFVgene, R202Q

Is MEFVGene Arg202Gln (605 G>A) A Disease-Causing Mutation?

Keywords:

Familial Mediterranean fever (FMF), amyloidosis, MEFVgene, R202Q,

PDF

___

1. El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet 2006; 367(9515): 1016-24.
2. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314(16): 1001-5.
3. Turkish FMF study group. Familial Mediterranean fever in Turkey: results of a nationwide study. Medicine 2005; 84: 1-11.
4. Centola M, Aksentijevich.I, Kastner DL. The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 1998; 7: 1581-8.
5. http://fmf.igh.cnrs.fr/infevers/
6. Livneh A, Langevita P, Zemer D, Zaks N, Kees S, Lidar T et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879-85.
7. Akar N, Akar E, Özel D, Tekin M, Ekim M, Yalç›nkaya F. A note on mutation analysis in familial Mediterranean fever. Pediatr Nephrol 2003; 18: 196-7.
8. Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 2000; 15: 118-9.
9. Y›lmaz E, Ozen S, Balc› B, Duzova A, Topaloglu R, Besbas N et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9(7): 553-5.
10. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25–31.
11. International FMF Consortium. Ancient missense mutations in a new member of the Roret gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797–807.
12. Ben-Cherit E. Familial Mediterranean fever (FMF) and renal AA amyloidosis-phenotype genotype correlation, treatment and prognosis. J Nephrol 2003; 16(3): 431-4.
13. Touitou I. The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473–83.
14. Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet 2007; 71(5): 458-67.